Raphael Eric Steiner, M.D.

Peer-Reviewed Articles

1. Paolo Strati, Loretta J Nastoupil, Jason Westin, Luis E Fayad, Sairah Ahmed, Nathan H Fowler, Fredrick B Hagemeister, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael Wang, Chelsea C Pinnix, Sherry Adkins, Catherine M Claussen, Charles S Martinez, Misha C Hawkins, Nicole A Johnson, Prachee Singh, Haleigh E Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J Shpall, Sattva S Neelapu, Sudhakar Tummala, T Linda Chi. Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv, 2020. PMID: 32822484.
2. Fateeha Furqan, Grace Watson, Felipe Samaniego, Luis E Fayad, Michael W Morrison, Philip A Thompson, Raphael E Steiner, Linda Chi, Bouthaina Dabaja, Chelsea C Pinnix, Sattva S Neelapu, Loretta J Nastoupil, Paolo Strati. Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement. Leuk Lymphoma, 2020. PMID: 32650677.
3. Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, Paolo Strati, Penny Fang, Misha C Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E Steiner, Swaminathan P Iyer, M Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S Neelapu, Loretta J Nastoupil. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. Blood Adv, 2020. PMID: 32589728.
4. Trevor B Cabrera, Wei Wang, Sireesha Yedururi, John M Slopis, Raphael E Steiner, Michael E Rytting, Branko Cuglievan. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review. J Pediatr Hematol Oncol, 2020. PMID: 32366782.
5. Gordon Glober, Jillian Gunther, Penny Fang, Sarah Milgrom, Brinda Rao Korivi, Corey T Jensen, Nicolaus A Wagner-Bartak, Sairah Ahmed, Hun Ju Lee, Ranjit Nair, Raphael Steiner, Simrit Parmar, Swaminathan Iyer, Jason Westin, Luis Fayad, M Alma Rodriguez, Sattva Neelapu, Loretta Nastoupil, Christopher R Flowers, Bouthaina S Dabaja, Chelsea C Pinnix. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. Clin Lymphoma Myeloma Leuk, 2020. PMID: 32291233.
6. Jillian R Gunther, Chelsea C Pinnix, Gordon R Glober, Kaitlin M Christopherson, Penny Fang, Hun Ju Lee, Sairah Ahmed, Raphael E Steiner, Ranjit Nair, Paolo Strati, Sattva S Neelapu, Loretta J Nastoupil, Bouthaina S Dabaja. Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?. EJHaem, 2020. PMID: 32864660.
7. Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, Chi Young Ok, Shaojun Zhang, Krystle Nomie, Guangchun Han, Dapeng Hao, Holly A Hill, Changying Jiang, Yixin Yao, Loretta Nastoupil, Jason Westin, Luis Fayad, Ranjit Nair, Raphel Steiner, Sairah Ahmed, Felipe Samaniego, Swaminathan P Iyer, Onyeka Oriabure, Wendy Chen, Xingzhi Song, Jianhua Zhang, Maria Badillo, Omar Moghrabi, Jorge Aranda, Guilin Tang, C Cameron Yin, Keyur Patel, Leonard Jeffrey Medeiros, Shaoying Li, Francisco Vega, Selvi Thirumurthi, Guofan Xu, Sattva Neelapu, Christopher R Flowers, Jorge Romaguera, Nathan Fowler, Linghua Wang, Michael L Wang, Preetesh Jain. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol, 2020. PMID: 32239765.
8. Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS. Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood Adv 3(9):1356-1367, 2019. PMID: 31036721.
9. Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs , Dietrich PY. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland. Swiss Med Wkly 148:w14596, 2018. e-Pub 2018. PMID: 29518251.
10. Steiner RE, Romaguera J, Wang M. Current trials for frontline therapy of mantle cell lymphoma. J Hematol Oncol 11(1):13, 2018. e-Pub 2018. PMID: 29374487.
11. Steiner RE, Orlowski RZ, Lee HC. Acute Pancreatitis Associated with Ixazomib in a Multiple Myeloma Patient. Acta Haematol 139(1):67-70, 2018. e-Pub 2018. PMID: 29402766.
12. Steiner RE, Manasanch EE. Carfilzomib boosted combination therapy for relapsed multiple myeloma. Onco Targets Ther 10:895-907, 2017. e-Pub 2017. PMID: 28243125.
13. Steiner R, Beyer J. [Post treatment follow-up of patients with testicular cancer by primary care physicians]. Praxis (Bern 1994) 103(3):125-32; quiz 131, 2014. PMID: 24468451.
14. Chaudhry M, Steiner R, Claussen C, Patel K, Lee H, Weber D, Thomas S, Feng C, Amini B, Orlowski R, Feng L, Manasanch EE. Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström's macroglobulinemia. Leuk Lymphoma:1-7. e-Pub 2018. PMID: 30227761.

Abstracts

1. Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Real Life Treatment Alterations of Frontline Therapies in Classic Hodgkin's Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 23–24), 2020.
2. Paolo Strati, MD, Grace Watson, Sandra B. Horowitz, Pharm.D., Ranjit Nair, MD, Maria Alma Rodriguez, MD, Raphael Eric Steiner, MD, Luis Fayad, Jason R. Westin, MD, Sattva S. Neelapu, MD. Clinical Efficacy of Polatuzumab Vedotin in Patients with Relapsed/Refractory Large B-Cell Lymphoma after Standard of Care Axicabtagene Ciloleucel. Blood(Blood (2020) 136 (Supplement 1): 16–17), 2020.
3. Ranjit Nair, MD, Samer Al Hadidi, MD MSc, FACP, Raphael Eric Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swaminathan P Iyer, MD, Penny Fang, MD, Jillian R. Gunther, MD PhD, Preetesh Jain, MBBS,MDDM,PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Association of Vitamin D Deficiency with Inferior Treatment Outcomes in Patients with Newly Diagnosed Classic Hodgkin Lymphoma: MD Anderson Cancer Center Experience. Blood(Blood (2020) 136 (Supplement 1): 27–28), 2020.
4. Raphael Eric Steiner, MD, Melody R. Becnel, MD, Branko Cuglievan, MD, Ranjit Nair, Prachee Singh, Paolo Strati, MD, Preetesh Jain, MBBS,MDDM,PhD, Sairah Ahmed, MD, Felipe Samaniego, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Penny Fang, MD, Bouthaina S. Dabaja, MD, Lei Feng, MS, Hun Ju Lee, MD. Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant. Blood(Blood (2020) 136 (Supplement 1): 28–29), 2020.
5. Swami P. Iyer, MD, Jie Xu, MD, Melody R. Becnel, MD, Ranjit Nair, MD, Raphael Steiner, MD, Lei Feng, MS, Hun Ju Lee, MD, Paolo Strati, MD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Yago Nieto, MD, Chitra Hosing, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ann Vo, Felipe Samaniego, MD, Nathan H. Fowler, MD, Neeraj Saini, MD, Issa F. Khouri, MD, Jin S. Im, Preetesh Jain, MBBS,MDDM,PhD, Luis Fayad, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Christopher Flowers, MDMS, Sattva S. Neelapu, MD. A Phase II Study of Pembrolizumab in Combination with Romidepsin Demonstrates Durable Responses in Relapsed or Refractory T-Cell Lymphoma (TCL). Blood(Blood (2020) 136 (Supplement 1): 40–41), 2020.
6. Vivian Changying Jiang, PhD, Shaojun Zhang, PhD, Junwei Lian, PhD, Yuanxin Wang, Rongjia Zhang, Yang Liu, PhD, Joseph McIntosh, BS, Guangchun Han, Ruiping Wang, PhD, David Santos, Maria Badillo, MSN, RN, OCN, CCRP, Angela Leeming, Zhihong Chen, Kimberly Hartig, John Bigcal, Hun Lee, MD, Raphael Eric Steiner, MD, Jorge Enrique Romaguera, MD, Preetesh Jain, MBBS,MDDM,PhD, Krystle Nomie, PhD, Andy Futreal, Linghua Wang, MDPhDMS, Michael Wang, MD. Single Cell Transcriptomic Evolution and Resistance Mechanisms of BTK and BCL-2 Inhibition in Mantle Cell Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 33–34), 2020.
7. Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Association of Smoking with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 34–35), 2020.
8. Sushanth Gouni, MD, Paolo Strati, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Raphael E Steiner, MD, Ranjit Nair, MD, Luis Fayad, Sattva S. Neelapu, MD, Ralf Landgraf, PhD, Daniel Bilbao, PhD, Francisco Vega, MDPhD, Nitin Agarwal, PhD. Use of Medium Potency Statins Is Associated with Improved Outcomes after Frontline RCHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Blood(Blood (2020) 136 (Supplement 1): 45), 2020.
9. Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD. Association of Epstein-Barr Virus with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 37–38), 2020.
10. Samer A. Srour, MD MS, Jie Xu, MD, Taha Al-Juhaishi, MD, Raphael Eric Steiner, MD, Joe Ensor, PhD, Sairah Ahmed, MD, Simrit Parmar, MD, MSCI, Paolo Strati, MD, Loretta J. Nastoupil, MD, Yago Nieto, MD, Chitra Hosing, MD, Hun Ju Lee, MD, Jason Westin, MD, Nathan H. Fowler, MD, Luis Fayad, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Penny Fang, MD, Felipe Samaniego, MD, Preetesh Jain, MBBS,MDDM,PhD, Richard E. Champlin, MD, Issa F. Khouri, MD, Michael Wang, MD, Roberto N. Miranda, MD, Francisco Vega, MDPhD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Swami P. Iyer, MD. Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center. Blood(Blood (2020) 136 (Supplement 1): 27–28), 2020.
11. Preetesh Jain, MBBS,MDDM,PhD, Rashmi Kanagal-Shamanna, MD, Lucy Navsaria, MB BCh BAO, Chi Young Ok, MD, Holly Hill, Dayoung Jung, Graciela M. Nogueras González, MPH, Hun Ju Lee, MD, Ranjit Nair, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Guilin Tang, MD, Shaoying Li, MD, Keyur Patel, MD PhD, Selvi Thirumurthi, Pan Tinsu, Guofang Xu, MD, Francisco Vega, MDPhD, Christopher Flowers, MDMS, Michael Wang, MD. Comprehensive Analysis of Factors Predictive for Time to Transformation and Risk of Transformation in Patients (pts) with Mantle Cell Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 41–42), 2020.
12. Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD. Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience. Blood(Blood (2020) 136 (Supplement 1): 17–18), 2020.
13. Paolo Strati, MD, Haleigh Mistry, Brittany Pulsifer, Luis Fayad, Sairah Ahmed, MD, Hun Ju Lee, MD, Swami P. Iyer, MD, Ranjit Nair, MD, Loretta J. Nastoupil, MD, Simrit Parmar, MD, MSCI, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Raphael Eric Steiner, MD, Michael Wang, MD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Mansoor Noorani, Catherine M. Claussen, MS, Elizabeth J. Shpall, MD, Partow Kebriaei, MD, Chris R. Flowers, MD MS, Jason R. Westin, MD, Sattva S. Neelapu, MD. Prognostic Value of Delta Lymphocyte Index (DLIx) in Patients with Large B-Cell Lymphoma (LBCL) Treated with Chimeric Antigen Receptor (CAR) T-Cell Therapy. Blood(Blood (2020) 136 (Supplement 1): 23–24), 2020.
14. Neeraj Saini, MD, Chia-Chi Chang, PhD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Jason Westin, MD, Ranjit Nair, MD, Luis Fayad, Sairah Ahmed, MD, Hun Ju Lee, MD, Swaminathan P Iyer, MD, Raphael Eric Steiner, MD, Uri Greenbaum, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Nitin Jain, MD, Michael R Green, PhD, Nadim J Ajami, Christopher Flowers, MDMS, Richard E. Champlin, MD, Jennifer Wargo, MD, Sattva S. Neelapu, MD, Robert R. Jenq, MD. Gut Bacterial Diversity Associates with Efficacy of Anti-CD19 CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma. Blood(Blood (2020) 136 (Supplement 1): 34–35), 2020.
15. Carla Casulo, MD, Myla Strawderman, MS, Raphael Steiner, MD, Carolyne Delage, MD, Tina Faugh, Matthew J. Maurer, MS, Brian K. Link, MD, Allison C. Rosenthal, D.O., Colleen Ramsower, B.S. M.B., Richard Burack, MD PhD, Sergei Syrbu, MD PhD, Andrew L. Feldman, MD, Philip J Rock, James R. Cerhan, MD PhD, Christopher Flowers, MDMS, Lisa M. Rimsza, MD, Jonathan W. Friedberg, MD MSSc. Describing Treatment of Primary Mediastinal Large B Cell Lymphoma Using Rigorously Defined Molecular Classification: A Retrospective Analysis. Blood(Blood (2020) 136 (Supplement 1): 35–36), 2020.
16. Preetesh Jain, MBBS,MDDM,PhD, Yixin Yao, PhD, Shuangtao Zhao, PhD, Yang Liu, PhD, Holly Hill, Yuxuan Che, Yijing Li, MS, Alexa A Jordan, BS, Joseph McIntosh, BS, Hun Ju Lee, MD, Raphael Eric Steiner, MD, Felipe Samaniego, MD, Jason Westin, MD, Loretta J. Nastoupil, MD, Ranjit Nair, Sairah Ahmed, MD, Chi Young Ok, MD, Rashmi Kanagal-Shamanna, MD, Onyeka Oriabure, Guofang Xu, MD, Wendy Chen, Omar Moghrabi, Chloe Marie McClain, Maria Badillo, MSN, RN, OCN, CCRP, Selvi Thirumurthi, David Santos, Cezar Iliescu, MD, C. Cameron Yin, MD PhD, Shaoying Li, MD, Guilin Tang, MD, Francisco Vega, MDPhD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Linghua Wang, PhD, Michael Wang, MD. Combination of Ibrutinib with Rituximab (IR) in Previously Untreated Older Patients with Mantle Cell Lymphoma (MCL) - a Phase II Clinical Trial. Blood(Blood (2020) 136 (Supplement 1): 41–42), 2020.
17. Hua-Jay J Cherng, MD, Raphael E Steiner, MD, Luis Fayad, Paolo Strati, MD, Ranjit Nair, MD, F. B. B. Hagemeister, MD, Loretta J. Nastoupil, MD, Hun Ju Lee, MD, Sattva S. Neelapu, MD, Christopher Flowers, MDMS, Felipe Samaniego, MD, Maria Alma Rodriguez, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Jason R. Westin, MD. Persistent Overall Response on Early PET/CT Scans during Salvage Therapy for Relapsed or Refractory DLBCL Predicts for Disease Specific Survival. Blood(Blood (2020) 136 (Supplement 1): 7–8), 2020.
18. Uri Greenbaum, MD, Paolo Strati, MD, Rima M. Saliba, PhD, Janet Torres, Gabriela Rondon, Yago Nieto, MD, Chitra Hosing, MD, Samer A. Srour, MD MS, Jason Westin, MD, Luis Fayad, Hun Ju Lee, MD, Swaminathan P Iyer, MD, Loretta J. Nastoupil, MD, Simrit Parmar, MD, MSCI, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Raphael Eric Steiner, MD, Michael Wang, MD, Chelsea C. Pinnix, MD PhD, Christopher Flowers, MDMS, Sudhakar Tummala, MD, Jeremy Ramdial, MD, Fevzi F. Yalniz, Misha Hawkins, Katayoun Rezvani, MD PhD, Richard E. Champlin, MD, Elizabeth J. Shpall, MD, Sattva S. Neelapu, MD, Partow Kebriaei, MD, Sairah Ahmed, MD. The Easix (Endothelial Activation and Stress Index) Score Predicts for CAR T Related Toxicity in Patients Receiving Axicabtagene Ciloleucel (axi-cel) for Non-Hodgkin Lymphoma (NHL). Blood(Blood (2020) 136 (Supplement 1): 17–18), 2020.
19. Paolo Strati, fateeha furqan, Jason Westin, Luis Fayad, Sairah Ahmed, Hun Ju Lee, Swaminathan Padmanabhan Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphael Steiner, Michael Wang, Chelsea Camille Pinnix, Christopher Flowers, Sandra B. Horowitz, Catherine Classen, Haleigh Mistry, Sattva Swarup Neelapu. Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel). ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr 8011)), 2020.
20. Sairah Ahmed, fateeha furqan, Paolo Strati, Jason Westin, Luis Fayad, Frederick B. Hagemeister, Hun Ju Lee, Swaminathan Padmanabhan Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphael Steiner, Michael Wang, Chelsea Camille Pinnix, Christopher Flowers, Sandra B. Horowitz, Misha Hawkins, Sattva Swarup Neelapu. Haemophagocytic lymphohistiocytosis (HLH) in patients with large B-cell lymphoma treated with standard of care (SOC) axicabtagene ciloleucel (Axi-cel). ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr 8057)), 2020. e-Pub 2020.
21. Raphael Steiner, Frederick M Cramer, Prachee Singh, Melody Becnel, Pedro E Alcedo, Collin K Chin, Branko Cuglievan, Paolo Strati, Sairah Ahmed, Felipe Samaniego, Ranjit Nair, Jillian Rebecca Gunther, Chelsea Camille Pinnix, Penny Fang, Bouthaina Shbib Dabaja, Lei Feng, Hun Ju Lee. Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin’s lymphoma in a real-world setting. ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr e20020)), 2020. e-Pub 2020.
22. Ranjit Nair, Chelsea Camille Pinnix, Jillian Rebecca Gunther, Paolo Strati, Jason Westin, Luis Fayad, Fredrick B. Hagemeister, Swaminathan Padmanabhan Iyer, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Raphael Steiner, Bouthaina Shbib Dabaja, Penny Fang, Christopher Flowers, Mansoor Noorani, Lei Feng, Sattva Swarup Neelapu, Sairah Ahmed, Hun Ju Lee. M.D. Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma. ASCO Abstract(J Clin Oncol 38: 2020 (suppl; abstr e20013)), 2020. e-Pub 2020.
23. Jason Westin, Loretta J. Nastoupil, Luis Fayad, Fredrick B. Hagemeister, Yasuhiro Oki, Francesco Turturro, Sairah Ahmed, Maria Alma Rodriguez, Hun Ju Lee, Raphael Steiner, Ranjit Nair, Simrit Parmar, Ken H Young, Timothy McDonnell, Hubert Chuang, Michael Richard Green, Sattva Swarup Neelapu, Richard Eric Davis. Smart start: Final results of rituximab, lenalidomide, and ibrutinib lead in prior to combination with chemotherapy for patients with newly diagnosed diffuse large B-cell lymphoma. ASCO Abstract, 2019.
24. Kartik Anand, Ethan Burns, Dahlia Sano, Sai Ravi Pingali, Jason Westin, Loretta J. Nastoupil, Hun Ju Lee, Felipe Samaniego, Simrit Parmar, Michael Wang, Misha Hawkins, Sherry Adkins, Luis Fayad, Raphael Steiner, Ranjit Nair, Sairah Ahmed, Nathan Hale Fowler, Sattva Swarup Neelapu, Swaminathan Padmanabhan Iyer;. Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS. ASCO Abstract(Abstract No: 2540), 2019.
25. J.R. Westin, L. Nastoupil, F. Hagemeister, L. Fayad, K. Young, T. McDonnell, H. Chuang, S. Ahmed, R. Nair, R. Steiner, H. Lee, M. Rodriguez, S. Parmar, M. Green, S. Neelapu, R. Davis. SMART START: RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE PRIOR TO COMBINATION WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA. Hematological ONCOLOGY ICML Abstract(Abstract No: 042), 2019.
26. J.R. Westin, L. Nastoupil, L. Fayad, F. Hagemeister, K. Young, T. McDonnell, S. Neelapu, R.E. Davis, M. Green, S. Ahmed, R. Nair, R. Steiner, H. Lee, M. Rodriguez, S. Parmar, H. Chuang. VERY EARLY FDG PET/CT SCAN MAY PREDICT OUTCOMES IN RELAPSED OR REFRACTORY DLBCL PATIENTS TREATED WITH SALVAGE THERAPY. Hematological ONCOLOGY ICML Abstract(Abstract No: 367), 2019.
27. B. Dabaja, M. Gule-Monroe, J.R. Gunther, S. Milgrom, T. Sheu, R. Nair, S. Ahmed, R. Steiner, P. Strati, L. Nastoupil, S. Neelapu, C. Pinnix, N. Fowler. DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME?. Hematological ONCOLOGY ICML Abstract(Abstract No: 406), 2019.
28. P. Strati, P. Alcedo Andreade, D. Sano, V. Rao, P. Singh, R. Miranda, J. Gunther, C. Pinnix, B. Dabaja, H.J. Lee, R. Steiner. RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER. Hematological ONCOLOGY ICML Abstract(Abstract No: 471), 2019.
29. Jason R. Westin, MD , Nathan H. Fowler, MD , Loretta J. Nastoupil, MD MSc , Sattva S Neelapu, MD , Hun Ju Lee , Fredrick B. Hagemeister, MD , Maria Alma Rodriguez, MD , Raphael E Steiner, MD , Sairah Ahmed, MD , Simrit Parmar, MBBS , Ranjit Nair, MBBS,MD , Rebecca Harrison, MD , Luis Fayad, MD. A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 4086), 2019.
30. Ariela Noy, MD , Timothy S. Pardee, MD PhD , Liana Nikolaenko, MD , Raphael Eric Steiner, MD , Jeremy S. Abramson, MD MMSc , Kieron Dunleavy, MD , Sanjeev Luther, MBA. A Phase II Clinical Trial of Cpi-613 (devimistat) in Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma with Rearrangements of MYC and BCL2and/or BCL6. Blood(Blood (2019) 134 (Supplement_1): 4087), 2019.
31. Preetesh Jain, MBBS,MDDM,PhD , Shuangtao Zhao, PhD , Rashmi Kanagal-Shamanna, MD , Lucy Navsaria, MB BCh BAO , Holly Hill , Ankita Misra , Krystle Nomie, PhD , Changying Jiang, PhD , Yixin Yao, PhD , Liang Zhang, MD PhD , Loretta J. Nastoupil, MD MSc , F. B. Hagemeister, MD , Jason R. Westin, MD , Ranjit Nair, MD , Raphael Eric Steiner, MD , Onyeka Oriabure , Wendy Chen , Guilin Tang, MD , C. Cameron Yin, MD PhD , Keyur Patel, MD PhD , Jorge Enrique Romaguera, MD , Nathan H. Fowler, MD , Linghua Wang, PhD , Michael L. Wang, MD. Non-Bcl2 Mutations Are Predominant in Patients (pts) with Venetoclax Resistant Mantle Cell Lymphoma (MCL) - Response and Clinical Outcomes in Ultra-Refractory MCL. Blood(Blood (2019) 134 (Supplement_1): 2815), 2019.
32. Preetesh Jain, MBBS,MDDM,PhD , Hun Ju Lee, MD , Raphael Eric Steiner, MD , F. B. Hagemeister, MD , Felipe Samaniego, MD , Jason R. Westin, MD , Loretta J. Nastoupil, MD MSc , Sairah Ahmed, MD , Swaminathan P. Iyer, MD , Jorge Enrique Romaguera, MD , Shuangtao Zhao, PhD , Krystle Nomie, PhD , Chi Young Ok, MD , Rashmi Kanagal-Shamanna, MD , Onyeka Oriabure , Guofang Xu, MD , Liang Zhang, MD PhD , Changying Jiang, PhD , Dayoung Jung , Lucy Navsaria, MB BCh BAO , Wendy Chen , Omar Moghrabi , Tayyaba Nizam , Chloe Marie McClain , Maria Badillo , Selvi Thirumurthi , David Santos , Guilin Tang, MD , Keyur Patel, MD PhD , Sattva S Neelapu, MD , Linghua Wang, PhD , Nathan H. Fowler, MD , Michael L. Wang, MD. Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (≥65 years) Patients with Mantle Cell Lymphoma (MCL) - Results from a Phase II Trial. Blood(Blood (2019) 134 (Supplement_1): 3988), 2019.
33. Jason R. Westin, MD , Loretta J. Nastoupil, MD MSc , Luis Fayad, MD , Fredrick B. Hagemeister, MD , Yasuhiro Oki, MD , Francesco Turturro, MD , Sairah Ahmed, MD , Maria Alma Rodriguez, MD , Hun Ju Lee , Raphael Eric Steiner, MD , Ranjit Nair, MBBS,MD , Simrit Parmar, MBBS , Ken H. Young , Timothy J. McDonnell, MD PhD , Hubert Chuang , Michael R Green, PhD , Sattva S Neelapu, MD , Eric Davis, MD. Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: Final Phase II Results. Blood(Blood (2019) 134 (Supplement_1): 1581), 2019.
34. Chelsea C Pinnix, MD PhD , Jillian R Gunther, MD PhD , Bouthaina S. Dabaja, MD , Sherry Adkins, ANP , Misha Hawkins , Jason R. Westin, MD , Luis Fayad, MD , Sairah Ahmed, MD , Nathan H. Fowler, MD , Fredrick B. Hagemeister, MD , Swaminathan P. Iyer, MD , Maria Alma Rodriguez, MD , Hun Ju Lee , Raphael E Steiner, MD , Ranjit Nair, MBBS,MD , Paolo Strati, MD , Simrit Parmar, MBBS , Felipe Samaniego, MD , Michael Wang, MD , Sattva S Neelapu, MD , Loretta J. Nastoupil, MD MSc. Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 1609), 2019. e-Pub 2019.
35. Paolo Strati, MD , Sudhakar Tummala , Loretta J. Nastoupil, MD MSc , Jason R. Westin, MD , Luis Fayad, MD , Sairah Ahmed, MD , Nathan H. Fowler, MD , F. B. Hagemeister, MD , Hun Ju Lee, MD , Swaminathan P. Iyer, MD , Ranjit Nair, MD , Simrit Parmar, MBBS , Maria Alma Rodriguez, MD , Felipe Samaniego, MD , Raphael Eric Steiner, MD , Michael L. Wang, MD , Chelsea Camille Pinnix, MD PhD , Sherry Adkins, ANP , Catherine M. Claussen, MS , Charles Martinez , Misha Hawkins , Nicole Johnson , Shirley George , Sattva S Neelapu, MD , Linda Chi, MD. Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 765), 2019. e-Pub 2019.
36. Nathan H Fowler, MD , Loretta J. Nastoupil, MD MSc , Collin Chin, MBBS , Paolo Strati, MD , Fredrick B. Hagemeister, MD , Luis E. Fayad, MD , Jason R. Westin, MD , Sheryl G Forbes , Janine Arafat , Lei Feng, MS , Ranjit Nair, MBBS,MD , Raphael E Steiner, MD , Felipe Samaniego, MD , Sattva S Neelapu, MD. A Phase I/II Study of Lenalidomide Plus Obinutuzumab in Relapsed Indolent Lymphoma. Blood(Blood (2019) 134 (Supplement_1): 348), 2019.
37. Loretta J. Nastoupil, MD MSc , Jason R. Westin, MD , Fredrick B. Hagemeister, MD , Hun Ju Lee , Luis Fayad, MD , Felipe Samaniego, MD , Sairah Ahmed, MD , Linda Claret , Raphael E Steiner, MD , Ranjit Nair, MBBS,MD , Simrit Parmar, MBBS , Maria Alma Rodriguez, MD , Michael L. Wang, MD , Michael R Green, PhD , Eric Davis, MD , Sattva S Neelapu, MD , Nathan H Fowler, MD. Results of a Phase II Study of Obinutuzumab in Combination with Lenalidomide in Previously Untreated, High Tumor Burden Follicular Lymphoma (FL). Blood(Blood (2019) 134 (Supplement_1): 125), 2019.
38. Dahlia Sano, MD , Paolo Strati, MD , Pedro Alcedo, MD , V Ahalya Rao, MD , Prachee Singh , Roberto N. Miranda, MD , Jillian R Gunther, MD PhD , Chelsea Camille Pinnix, MD PhD , Bouthaina S. Dabaja, MD , Feng Lei, MS , Hun Ju Lee, MD , Raphael E Steiner, MD. Maintenance Rituximab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in the First Line Setting or at Relapse. Blood(Blood (2019) 134 (Supplement_1): 5291), 2019.
39. Changying Jiang, PhD , Shaojun Zhang, PhD , Yuanxin Wang , Rongjia Zhang , Yang Liu, MD , Joseph Mitchell McIntosh , Guangchun Han, PhD , Ruiping Wang, PhD , David Santos , Maria Badillo , Angela Leeming , Zhihong Chen , Kimberly Hartig , John Bigcal , Hun Ju Lee , Raphael E Steiner, MD , Jorge Enrique Romaguera, MD , Preetesh Jain, MBBS, MDDM, PhD , Krystle Nomie, PhD , Andy Futreal, PhD , Linghua Wang, PhD , Michael L. Wang, MD. Transcriptomic Heterogeneity and Clonal Evolution Associated with Therapeutic Resistance in Mantle Cell Lymphoma Revealed By Single Cell RNA-Seq. Blood(Blood (2019) 134 (Supplement_1): 5217), 2019.
40. Dahlia Sano, Loretta J. Nastoupil, Nathan H. Fowler, Luis Fayad, F. B. Hagemeister, Hun Ju Lee, Felipe Samaniego, Michael Wang, Maria Alma Rodriguez, Swaminathan P Iyer, Simrit Parmar, Raphael Steiner, Ranjit Nair, Sherry Adkins, Sara Arafat, Ahalya Rao, Liliana Vallejo, Misha Hawkins, Yiming Chen, Jason R. Westin, and Sattva S. Neelapu. Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell LymphomaClinically Relevant Abstract. ASH Annual Meeting 2018, 2018.
41. Chaudhry M, Steiner RE, Claussen CM, Patel K, Lee HC, Weber DM, Thomas SK, Feng C, Kramer M, Amini B, Orlowski RZ, Feng L, Manasanch EE. Carfilzomib-Based Combination Regimens Are Highly Effective Frontline Therapies for Multiple Myeloma and Waldenström's Macroglobulinemia. ASH Abstract 130(Suppl 1):1880. e-Pub 2017.
42. Steiner RE, Fanale MA. New Strategies for the Treatment of Early Stage Classical Hodgkin Lymphoma (cHL). Clinical Lymphoma, Myeloma & Leukemia 17:S153–S155. e-Pub 2017.

Book Chapters

1. Karp DD, Falchook G. Lymphoma. In: Handbook of Targeted Cancer Therapy and Immunotherapy. second. Wolters Kluwer, 2018.